Panitumumab activity in metastatic colorectal cancer (mCRC) patients (pts) with low or negative tumor epidermal growth factor receptor (EGFr) levels: An updated analysis

被引：0
|
作者：
Mitchell, E. P.
Hecht, J. R.
Baranda, J.
Malik, I.
Richards, D.
Reiner, M.
Stout, S.
Amado, R. G.
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[3] VA Med Ctr, Kansas City, MO USA
[4] Loma Linda Canc Ctr, Loma Linda, CA USA
[5] Tyler Canc Ctr, Tyler, TX USA
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4082
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Progression of epidermal growth factor receptor (EGFR)-independent colorectal cancer
    Rojas, Carolina Mantilla
    Ming, Yu
    Threadgill, David
    [J]. CANCER RESEARCH, 2017, 77
  • [42] Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
    Malgorzata Banys-Paluchowski
    Isabell Witzel
    Sabine Riethdorf
    Brigitte Rack
    Wolfgang Janni
    Peter A. Fasching
    Erich-Franz Solomayer
    Bahriye Aktas
    Sabine Kasimir-Bauer
    Klaus Pantel
    Tanja Fehm
    Volkmar Müller
    [J]. Scientific Reports, 7
  • [43] Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
    Banys-Paluchowski, Malgorzata
    Witzel, Isabell
    Riethdorf, Sabine
    Rack, Brigitte
    Janni, Wolfgang
    Fasching, Peter A.
    Solomayer, Erich-Franz
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Pantel, Klaus
    Fehm, Tanja
    Mueller, Volkmar
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [44] Molecular imaging of colorectal tumor targeting epidermal growth factor receptor (EGFR)
    Miyamoto, Yoshihiko
    Tanaka, Hironori
    Okada, Yasuyuki
    Okazaki, Jun
    Miyoshi, Jinsei
    Taniguchi, Tatsuya
    Nakagawa, Tadahiko
    Sato, Yasushi
    Muguruma, Naoki
    Takayama, Tetsuji
    [J]. CANCER SCIENCE, 2018, 109 : 1380 - 1380
  • [45] Circulating tumor (ct) DNA captures intrapatient heterogeneity in metastatic colorectal (mCRC) patients (pts) progressing to FOLFIRI plus panitumumab
    Vidal, J.
    Vieitez, J. M.
    Paez, D.
    Santos, C.
    Falco, E.
    Lopez Lopez, C.
    Valladares-Ayerbes, M.
    Robles, L.
    Garcia-Alfonso, P.
    Duran Ogaya, G.
    Azuara, D.
    Dalmeses, A.
    Bellosillo Paricio, B.
    Capella, G.
    Salazar, R.
    Aranda Aguilar, E.
    Montagut, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [46] Role of circulating tumor DNA (ctDNA) in assessing primary antieepidermal growth factor receptor (EGFR) resistance in untreated RAS/BRAF wild-type (WT) metastatic colorectal cancer (mCRC) patients (pts)
    Loh, J.
    Choo, J.
    Sooi, K.
    Low, P.
    Ang, C. S.
    Sundar, R.
    Walsh, R. J.
    Wijaya, S.
    Low, J. L.
    Hsing, S.
    Jain, S.
    Chee, C. E.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S429 - S429
  • [47] Testing targeted demethylation to overcome resistance to epidermal growth factor receptor (EGFR) blocking agents in wild-type (wt) KRAS metastatic colorectal cancer patients (mCRC).
    Garrido-Laguna, Ignacio
    McGregor, Kimberly
    Wade, Mark
    Weis, John R.
    Burr, Laura
    Soldi, Raffaella
    Davidson, Cynthia
    Jakubowski, Loni
    Morrell, Glen
    Olpin, Jeffrey
    Jones, David
    Sharma, Sunil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] CIRCULATING AMPHIREGULIN (AR) PLASMA LEVELS AS SURROGATE PHARMACODYNAMIC MARKERS OF EGFR INHIBITION WITH CETUXIMAB IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS)
    Cremolini, C.
    Loupakis, F.
    Fioravanti, A.
    Lupi, C.
    Orlandi, P.
    Salvatore, L.
    Fontanini, G.
    Danesi, R.
    Bocci, G.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 68 - 68
  • [49] Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer
    Azuma, Mizutomo
    Danenberg, Kathleen D.
    Iqbal, Syma
    El-Khoueiry, Anthony
    Zhang, Wu
    Yang, Dongyun
    Koizumi, Wasaburo
    Saigenji, Katsunori
    Danenberg, Peter V.
    Lenz, Heinz-Josef
    [J]. CLINICAL COLORECTAL CANCER, 2006, 6 (03) : 214 - 218
  • [50] Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab
    Parseghian, Christine Megerdichian
    Beutner, Karl
    Boedigheimer, Michael
    Ruff, Paul
    Price, Timothy Jay
    Kim, Tae Won
    Fakih, Marwan
    Ang, Agnes
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345